| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-10 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-10 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-08 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-08 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-08 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.24 | 9e-08 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-07 |